RNA-TEC Overview
- Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
RNA-TEC General Information
Description
Producer of synthetic DNA and RNA intended to identify the carriers of genetic information. The company's technology unmodified as well as with base and/or sugar modifications - and non-radioactive isotopically labeled (13C and 15N) nucleic acid products, enabling researches in the large research institutes and pharmaceutical companies to deal with RNA specific research.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- Leuven
- Belgium
RNA-TEC Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 18-Sep-2006 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
RNA-TEC Patents
RNA-TEC Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-6900301-A | Labeled nucleosides and method for their preparation | Inactive | 10-May-2000 | 00000000000 |
RNA-TEC Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| KU Leuven Research & Development | Venture Capital | Minority | 000 0000 | 000000 0 |